AIRR - ANZCA Institutional Research Repository
Skip navigation
Please use this identifier to cite or link to this item: http://hdl.handle.net/11055/463
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMartin, Jennifer H-
dc.contributor.authorPhillips, Elizabeth-
dc.contributor.authorThomas, David-
dc.contributor.authorSomogyi, Andrew A-
dc.date.accessioned2018-04-08T01:04:34Z-
dc.date.available2018-04-08T01:04:34Z-
dc.date.issued2015-11-
dc.identifier.citationBritish journal of clinical pharmacology 2015-11; 80(5): 929-31-
dc.identifier.urihttp://hdl.handle.net/11055/463-
dc.language.isoeng-
dc.subject.meshNeoplasms-
dc.subject.meshPrecision Medicine-
dc.titleAdding the 'medicines' back into personalized medicine to improve cancer treatment outcomes.-
dc.typeEditorial-
dc.identifier.journaltitleBritish journal of clinical pharmacology-
dc.identifier.doi10.1111/bcp.12690-
dc.description.pubmedurihttps://www.ncbi.nlm.nih.gov/pubmed/26507561-
dc.identifier.pubmedid26507561-
Appears in Collections:Scholarly and Clinical

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.